TA0953/HM06, a novel RET-specific inhibitor effective in extracranial and CNS disease models of NSCLC with RETfusions Meeting Abstract
| Authors: | Odintsov, I.; Lui, A. J. W.; Delasos, L.; Khodos, I.; Chang, Q.; Mattar, M. S.; Vojnic, M.; Lu, Y. C.; Kunte, S.; Bonifacio, A.; Giuliano, C.; de Stanchina, E.; Lovati, E.; Ladanyi, M.; Somwar, R. |
| Abstract Title: | TA0953/HM06, a novel RET-specific inhibitor effective in extracranial and CNS disease models of NSCLC with RETfusions |
| Meeting Title: | 2022 World Conference on Lung Cancer |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 17 |
| Issue: | 9 Suppl. |
| Meeting Dates: | 2022 Aug 6-9 |
| Meeting Location: | Vienna, Austria |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2022-09-01 |
| Start Page: | S90 |
| End Page: | S91 |
| Language: | English |
| DOI: | 10.1016/j.jtho.2022.07.151 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl |
| DOI/URL: | |
| Notes: | Meeting Abstract: MA13.05 -- Located within section named "MA13 Update on ROS1 Inhibitors and New Pathways" -- Accession Number: 159037397 -- Entry Date: In Process -- Revision Date: 20220913 -- Publication Type: Article -- Supplement Title: 2022 Supplement -- Journal Subset: Biomedical; Blind Peer Reviewed; Peer Reviewed; USA -- NLM UID: 101274235. -- Source: Cinahl |
Altmetric
Citation Impact
BMJ Impact Analytics
